Активирующие мутации EGFR, ALK и ROS1 при НМРЛ стандарт выбора лечебной тактики, перспективы
Активирующие мутации EGFR, ALK и ROS1 при НМРЛ – стандарт выбора лечебной тактики, перспективы
д.м.н. Д.Д. Сакаева (Уфа)
2 months ago 01:28:53 20
2 months ago 00:12:30 19
2 months ago 00:29:15 1
3 months ago 00:13:51 1
3 months ago 00:20:52 1
3 months ago 00:14:39 1
3 months ago 00:15:40 1
3 months ago 00:22:34 1
3 months ago 00:25:06 1
3 months ago 00:16:33 1
3 months ago 00:23:47 8
3 months ago 00:16:32 1
3 months ago 00:06:14 1
3 months ago 00:24:11 1
3 months ago 00:18:35 1
3 months ago 00:25:01 3
3 months ago 00:23:20 3
3 months ago 00:28:28 1
3 months ago 00:39:29 1
3 months ago 00:31:19 1
3 months ago 01:28:58 1
3 months ago 00:18:47 1
3 months ago 00:22:46 1
3 months ago 00:31:34 4
